Zai Lab Limited ( NASDAQ: ZLAB) Discusses Updated Monotherapy Phase I Data for Zoci and Outlines Next Steps in Clinical Development October 24, 2025 11:00 AM EDT ...
While opportunities are vast, challenges such as limited mainstream retail presence and higher production costs compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback